Artelo Biosciences (ARTL) Earnings Date & Reports

A.I. Advisor

published Earnings

ARTL is expected to report earnings to fall 34.23% to -49 cents per share on November 05

Artelo Biosciences ARTL Stock Earnings Reports

Q3'24

Est.

$-0.49

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.13

Q4'23

Missed

by $0.43

Q3'23

Missed

by $0.18

The last earnings report on August 13 showed earnings per share of -75 cents, beating the estimate of -79 cents. With 2.52K shares outstanding, the current market capitalization sits at 3.52M.

View a ticker or compare two or three

Compare

ARTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARTL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

505 Lomas Santa Fe

Phone

+1 858 925-7049

Employees

Web

https://www.artelobio.com